I'm a 56-Year-Old Dermatologist. Here's What Medical School Never Taught Me About My Own Face After 45.

Almost nothing. I'm not exaggerating.

I want to tell you something my profession doesn't like to admit.

Four years of medical school. Four years of dermatology residency. Eight years total of postgraduate training.

The combined curriculum on skin biology in menopausal and postmenopausal women — when you add up the lectures, the readings, the case studies, the exam questions?

About two hours.

Two hours, across eight years, for the most common skin transition that 100% of female patients eventually go through.

We were trained to spot melanoma in a thirty-second exam. To do biopsies. To prescribe accutane. To inject filler.

We were not trained — in any meaningful, structured way — to explain to a 51-year-old woman why her face had structurally changed in 18 months.

Most of my colleagues fill that gap with the same script I gave that patient. Sunscreen. Retinol. Botox. Repeat.

It's not malpractice. It's just not enough.

And the reason it's not enough is not the fault of any individual dermatologist. It's the fault of a medical curriculum that treated perimenopausal skin biology as a footnote when it should have been a chapter.

I was 47. I knew the science of skin. I still got blindsided.

You'd think a dermatologist would notice the signs early.

I didn't.

I noticed something else first. A tightness across my cheeks at the end of the day that I'd never had before. The way my foundation started settling into lines around my mouth by 2pm.

Then I noticed my under-eyes had gotten… hollow. Not just darker. Hollow.

I told myself it was stress. I was running a busy practice. My oldest had just left for college. My estranged sister had just been diagnosed with something serious.

It made sense to blame the year I was having.

Then one morning, I caught my own jawline in the bathroom mirror at a specific angle — and the line I'd had my entire adult life was just… softer. Lower. Not where it used to be.

I am a dermatologist.

I knew what I was looking at.

And I still stood there for a long moment, telling myself I was imagining it.

Because here is what nobody tells you about being a doctor and going through this:

You are not allowed to be confused about your own body. Not in the way patients are allowed to be confused. You are supposed to have the answers.

And I didn't.

I bought the same things my patients buy. None of it worked.

I want to be honest about this because I think it matters.

In the 12 months after I noticed my jawline changing, I bought:

La Mer Crème de la Mer (yes, really — I rolled my eyes at myself while doing it).

Augustinus Bader The Cream.

A peptide serum from a brand my own colleague had told me to "try."

Two different retinol formulations from medical-grade brands I prescribe to patients.

A red-light therapy device that lives in my closet now.

None of it worked.

Not in the way I needed it to.

The retinol — even the medical-grade — burned. The peptide serum did something nice for hydration but didn't touch the structural change. La Mer felt luxurious and accomplished nothing measurable.

This is the part that humbled me.

I had spent eight years training in dermatology, and I had spent the previous year telling my own patients which products to buy. And here I was, sitting on my bathroom floor at 49 years old, looking at a $400 jar I'd bought on a Tuesday in October, realizing that I was as lost as any of my patients.

I had information. I had credentials. I had a Master's-level understanding of skin biology.

And the products I had access to — even the prescription-grade ones — were not built for what was happening to my face.

Boston. November 2024. A lecture I almost skipped.

I'm going to tell you about a lecture.

I was at a dermatology research conference in Boston, two years ago. The kind of conference where most of the panels are about new biologics for psoriasis and the latest data on Mohs surgery margins.

Late in the second day, there was a panel slotted into an off-hour timeblock — the kind nobody attends — called something like "Extracellular Matrix Degradation in Female Aging Skin: A Reframe of the Postmenopausal Skin Phenotype."

It sounded like a snooze.

I almost went back to my hotel.

I'm so glad I didn't.

The lead speaker was a researcher I'll call Dr. M. — she's still actively publishing and I want to respect her privacy. PhD in dermal biochemistry. Twenty years studying enzymes in human skin.

She got up to the podium and said, almost as her opening line:

"For the last forty years, our entire field has been studying one half of the collagen equation. We've studied production. We've barely studied destruction. And destruction is what's driving the visual collapse of skin in women over 45."

I sat up in my chair.

She spent the next 45 minutes walking through the data on Matrix Metalloproteinases — MMPs — and their behavior in skin where estrogen has dropped.

I was taking notes like I hadn't taken notes since medical school.

Here's the short version of what she taught.

I'll tell you this the way I'd tell you over coffee.

You have enzymes in your skin called MMPs — Matrix Metalloproteinases. They've always been there. Their job is to break down old, damaged collagen so your body can replace it with fresh collagen. It's a normal, healthy process.

In your 20s and 30s, this works beautifully. Destruction and rebuilding stay in balance. Demolition crew works. Construction crew works. The house stays standing.

Then perimenopause begins. Usually somewhere between 40 and 47.

Estrogen levels drop. And here's the critical piece: estrogen was the signal telling your skin's construction crew to keep building. When estrogen falls, the construction crew goes home.

But the demolition crew? They don't get the message. They keep working on the same schedule. Same pace. Same daily destruction.

You are now losing collagen faster than you are replacing it. Every day. For the rest of your life.

The numbers — and these are well-established in the dermatologic literature — are stark:

If you're 53 and entered perimenopause at 47, your face has already lost close to a third of its structural collagen.

That is not aging. That is biological collapse.

And it's the reason your jawline looks different. The reason your cheeks have flattened. The reason your skin has thinned around your eyes and mouth.

It is not a cosmetic issue. It is a biochemical one.

And here is the question that destroyed my career as I understood it before that lecture:

Why doesn't the average premium anti-aging product target MMPs?

The answer Dr. M. gave was uncomfortable.

Because targeting MMPs requires specific, expensive, harder-to-formulate active ingredients. Because "adding collagen" makes for better marketing copy than "inhibiting metalloproteinase activity." Because the industry has built a forty-year economy on creams that hydrate the surface while the substructure quietly dissolves underneath.

I walked out of that lecture and stood in the hotel hallway for ten minutes.

Furious is the right word.

Furious at my profession. Furious at the industry. Furious at the patient I'd failed six years earlier.

Furious that nobody had taught me this.

After Boston, I rewrote how I treat skin after 45.

I came back from Boston a different doctor.

The first thing I did was stop reflexively recommending the standard menu — sunscreen, retinol, Botox — to every woman over 45 who walked in.

The new model I adopted treats menopausal skin collapse as a three-front condition:

1. Barrier integrity. The lipid barrier breaks down when estrogen drops. Water escapes. Sensitivity rises. The barrier must be rebuilt before anything else works properly.

2. MMP inhibition. The single biggest gap in mainstream skincare. If you're not actively blocking the enzymes destroying your collagen, nothing else you do will hold.

3. Cellular renewal. Cell turnover slows dramatically after menopause — from 28 days in your 20s to 60 or 90 days in your 50s and 60s. Without renewal, dullness and texture problems compound.

For 12 months after Boston, I tested combinations. I tried prescription-grade peptide serums. I trialed three different retinol delivery systems with my patients. I read every paper I could find on silk-derived peptides and their MMP-inhibiting properties.

I am not going to pretend I tested everything on the market. I didn't. But I tested enough to learn that almost nothing in the prestige skincare space — the brands my patients were already spending hundreds of dollars on — was hitting all three fronts at once.

Almost nothing.

There was one exception.

This is the part where I need to be transparent.

What I'm about to tell you is the protocol I now recommend to my own patients in perimenopause and postmenopausal stages.

I want to be transparent before I name it.

The brand is ELYSERA.

The protocol is called The Silk Protocol.

It is three steps:

The full protocol is 90 seconds in the morning, 90 seconds at night.

That's it.

I have been using it personally for 14 months. My mother-in-law, 71, has been using it for 11 months. I have approximately 60 patients in my practice currently using it, ranging in age from 44 to 78.

The results are not magic. They are consistent.

Visible improvement in barrier integrity within 7–10 days. Measurable improvement in firmness around the jawline and cheeks within 4–6 weeks. Reduction in fine line depth, improvement in tone, and refinement of texture within 60 days for most users.

It does not work for everyone. Nothing does. But the percentage of patients who see meaningful structural improvement is higher with this protocol than with anything else I have used or prescribed in 25 years of practice.

Six years late. But I called her.

I want to finish with one more confession.

About four months after I started recommending The Silk Protocol in my practice, I pulled an old patient file.

The 51-year-old woman from the beginning of this letter. The one I had failed six years earlier.

She was now 57.

I had her number on file. I made the call.

She was kind enough to answer.

I told her — directly, without softening it — that I had failed her in 2019. That what I had told her then was the standard of care at the time, but that the standard of care was inadequate, and that I had since learned what she had actually been asking me about.

I told her about MMPs. About the three-front model. About the protocol I now recommended.

She was quiet for a long moment.

Then she said something I will think about for the rest of my career:

"Doctor. Thank you for calling. Nobody has ever called me back."

She came in two weeks later. She bought the protocol that night.

She has been using it for 9 months as of this writing.

Her jawline is back.

So is mine.

What I would tell you if you were sitting in my office today.

If you are reading this, I think there's a reasonable chance you are roughly where my old patient was in 2019.

You have noticed that something has changed in your face.

You have spent meaningful money trying to address it — premium creams, serums, devices, possibly some clinical procedures.

You have been quietly disappointed by most of it.

And somewhere in the back of your mind, you have started to consider whether this is just how it ends. Whether the face you have now is the face you'll have for the rest of your life, only progressively worse.

I want to tell you what nobody told my patient and what nobody told me:

It is not how it ends. It is a biological process that can be specifically addressed.

The reason most of what you've tried hasn't worked is not because you've been unlucky, or unfaithful to a routine, or insufficiently committed to your skincare. It's because the products you bought were not built for the specific biology of your skin at this stage.

You need a protocol that:

1. Rebuilds the barrier
2. Inhibits MMPs
3. Restores cell renewal

If the products in your bathroom right now don't do those three things — and most don't — they will not produce structural change. They will produce hydration, fragrance, ritual, and slight improvements in surface texture. They will not give you your jawline back.

The Silk Protocol does the three things above. It has a 60-day money-back guarantee. You can return empty bottles. The financial risk is genuinely transferred to the company.

I am recommending it the way I would recommend a medication to a patient — with the understanding that I am not promising it will work for you, but that the mechanism is sound, the evidence is real, and the risk to you of trying it is structured to be minimal.